{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:39:32Z","timestamp":1792201172745,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-025-02141-3","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:44:24Z","timestamp":1762166664000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Differential prognostic significance of tumor size and node in invasive lobular carcinoma of breast"],"prefix":"10.1186","volume":"27","author":[{"given":"Eunhye","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ik Beom","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Jung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyoung","family":"Byeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Ho","family":"Cheun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Byoel","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonshik","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4425-972X","authenticated-orcid":false,"given":"Hong-Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9981-0286","authenticated-orcid":false,"given":"Hyeong-Gon","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"2141_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin"},{"key":"2141_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4048\/jbc.2023.26.e27","volume":"26","author":"JE Choi","year":"2023","unstructured":"Choi JE, et al. Breast cancer statistics in Korea, 2019. J Breast Cancer. 2023;26:207\u201320. https:\/\/doi.org\/10.4048\/jbc.2023.26.e27.","journal-title":"J Breast Cancer"},{"key":"2141_CR3","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1093\/jnci\/djac157","volume":"114","author":"S Oesterreich","year":"2022","unstructured":"Oesterreich S, et al. Clinicopathological features and outcomes comparing patients with invasive ductal and lobular breast cancer. JNCI J Natl Cancer Inst. 2022;114:1511\u201322.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"2141_CR4","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10549-023-07022-x","volume":"201","author":"Y Adachi","year":"2023","unstructured":"Adachi Y, et al. Analysis of prognosis in different subtypes of invasive lobular carcinoma using the Japanese National Cancer Database-Breast Cancer Registry. Breast Cancer Res Treat. 2023;201:397\u2013408. https:\/\/doi.org\/10.1007\/s10549-023-07022-x.","journal-title":"Breast Cancer Res Treat"},{"key":"2141_CR5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10549-023-07044-5","volume":"201","author":"BF Chen","year":"2023","unstructured":"Chen BF, et al. Clinical characteristics and treatment outcomes of invasive ductal and lobular carcinoma: analyses of 54,832 Taiwan cancer registry index cases. Breast Cancer Res Treat. 2023;201:547\u201360. https:\/\/doi.org\/10.1007\/s10549-023-07044-5.","journal-title":"Breast Cancer Res Treat"},{"key":"2141_CR6","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1200\/JCO.2007.14.9336","volume":"26","author":"BC Pestalozzi","year":"2008","unstructured":"Pestalozzi BC, et al. Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials. J Clin Oncol. 2008;26:3006\u201314.","journal-title":"J Clin Oncol"},{"key":"2141_CR7","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","volume":"163","author":"G Ciriello","year":"2015","unstructured":"Ciriello G, et al. Comprehensive molecular portraits of invasive lobular breast cancer. Cell. 2015;163:506\u201319.","journal-title":"Cell"},{"key":"2141_CR8","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1200\/JCO.1995.13.7.1578","volume":"13","author":"P Broet","year":"1995","unstructured":"Broet P, et al. Contralateral breast cancer: annual incidence and risk parameters. J Clin Oncol. 1995;13:1578\u201383.","journal-title":"J Clin Oncol"},{"key":"2141_CR9","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s00428-003-0881-4","volume":"443","author":"T Tot","year":"2003","unstructured":"Tot T. The diffuse type of invasive lobular carcinoma of the breast: morphology and prognosis. Virchows Arch. 2003;443:718\u201324.","journal-title":"Virchows Arch"},{"key":"2141_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.breast.2004.03.004","volume":"13","author":"J Molland","year":"2004","unstructured":"Molland J, et al. Infiltrating lobular carcinoma\u2014a comparison of diagnosis, management and outcome with infiltrating duct carcinoma. Breast. 2004;13:389\u201396.","journal-title":"Breast"},{"key":"2141_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1200\/JCO.2005.03.111","volume":"23","author":"M Cristofanilli","year":"2005","unstructured":"Cristofanilli M, et al. Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol. 2005;23:41\u20138.","journal-title":"J Clin Oncol"},{"key":"2141_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/bcr767","volume":"6","author":"G Arpino","year":"2004","unstructured":"Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res. 2004;6:1\u20138.","journal-title":"Breast Cancer Res"},{"key":"2141_CR13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ejso.2013.02.007","volume":"39","author":"N Biglia","year":"2013","unstructured":"Biglia N, et al. Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC). Eur J Surg Oncol (EJSO). 2013;39:455\u201360.","journal-title":"Eur J Surg Oncol (EJSO)"},{"key":"2141_CR14","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.breast.2021.07.011","volume":"59","author":"C Chamalidou","year":"2021","unstructured":"Chamalidou C, et al. Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up. Breast. 2021;59:294\u2013300.","journal-title":"Breast"},{"key":"2141_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.590643","volume":"10","author":"C Yang","year":"2020","unstructured":"Yang C, et al. Comparison of overall survival between invasive lobular breast carcinoma and invasive ductal breast carcinoma: a propensity score matching study based on SEER database. Front Oncol. 2020;10:590643.","journal-title":"Front Oncol"},{"key":"2141_CR16","doi-asserted-by":"publisher","first-page":"e2342270","DOI":"10.1001\/jamanetworkopen.2023.42270","volume":"6","author":"TI Yoon","year":"2023","unstructured":"Yoon TI, et al. Survival outcomes in premenopausal patients with invasive lobular carcinoma. JAMA Netw Open. 2023;6:e2342270\u2013e2342270.","journal-title":"JAMA Netw Open"},{"key":"2141_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10549-022-06572-w","volume":"193","author":"JA Mouabbi","year":"2022","unstructured":"Mouabbi JA, et al. Invasive lobular carcinoma: an understudied emergent subtype of breast cancer. Breast Cancer Res Treat. 2022;193:253\u201364.","journal-title":"Breast Cancer Res Treat"},{"key":"2141_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-020-01384-6","volume":"23","author":"AE McCart Reed","year":"2021","unstructured":"McCart Reed AE, Kalinowski L, Simpson PT, Lakhani SR. Invasive lobular carcinoma of the breast: the increasing importance of this special subtype. Breast Cancer Res. 2021;23:1\u201316.","journal-title":"Breast Cancer Res"},{"key":"2141_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1053\/j.seminoncol.2019.03.002","volume":"46","author":"M Thomas","year":"2019","unstructured":"Thomas M, Kelly ED, Abraham J, Kruse M. Invasive lobular breast cancer: a review of pathogenesis, diagnosis, management, and future directions of early stage disease. Semin Oncol. 2019;46:121\u201332. https:\/\/doi.org\/10.1053\/j.seminoncol.2019.03.002.","journal-title":"Semin Oncol"},{"key":"2141_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4048\/jbc.2022.25.e35","volume":"25","author":"SY Kim","year":"2022","unstructured":"Kim SY, Cho N. Breast magnetic resonance imaging for patients with newly diagnosed breast cancer: a review. J Breast Cancer. 2022;25:263\u201377. https:\/\/doi.org\/10.4048\/jbc.2022.25.e35.","journal-title":"J Breast Cancer"},{"key":"2141_CR21","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1038\/sj.onc.1203785","volume":"19","author":"ZM Shao","year":"2000","unstructured":"Shao ZM, Nguyen M, Barsky SH. Human breast carcinoma desmoplasia is PDGF initiated. Oncogene. 2000;19:4337\u201345. https:\/\/doi.org\/10.1038\/sj.onc.1203785.","journal-title":"Oncogene"},{"key":"2141_CR22","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1158\/2159-8290.CD-12-0107","volume":"2","author":"RA DeFilippis","year":"2012","unstructured":"DeFilippis RA, et al. CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues. Cancer Discov. 2012;2:826\u201339. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0107.","journal-title":"Cancer Discov"},{"key":"2141_CR23","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374\u2013403. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.016.","journal-title":"Cancer Cell"},{"key":"2141_CR24","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/annonc\/mdz235","volume":"30","author":"HJ Burstein","year":"2019","unstructured":"Burstein HJ, et al. Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019. Ann Oncol. 2019;30:1541\u201357.","journal-title":"Ann Oncol"},{"key":"2141_CR25","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for breast cancer. (2024 National ComprehensiveCancer Network, Inc. )."},{"key":"2141_CR26","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1245\/s10434-010-0953-z","volume":"17","author":"N Wasif","year":"2010","unstructured":"Wasif N, Maggard MA, Ko CY, Giuliano AE. Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes. Ann Surg Oncol. 2010;17:1862\u20139. https:\/\/doi.org\/10.1245\/s10434-010-0953-z.","journal-title":"Ann Surg Oncol"},{"key":"2141_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.591399","volume":"10","author":"N Wilson","year":"2021","unstructured":"Wilson N, Ironside A, Diana A, Oikonomidou O. Lobular breast cancer: a review. Front Oncol. 2021;10:591399.","journal-title":"Front Oncol"},{"key":"2141_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1148\/rg.291085100","volume":"29","author":"JK Lopez","year":"2009","unstructured":"Lopez JK, Bassett LW. Invasive lobular carcinoma of the breast: spectrum of mammographic, US, and MR imaging findings. Radiographics. 2009;29:165\u201376.","journal-title":"Radiographics"},{"key":"2141_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2193-1801-3-70","volume":"3","author":"U Narbe","year":"2014","unstructured":"Narbe U, et al. Invasive lobular carcinoma of the breast: long-term prognostic value of Ki67 and histological grade, alone and in combination with estrogen receptor. Springerplus. 2014;3:1\u201311.","journal-title":"Springerplus"},{"key":"2141_CR30","doi-asserted-by":"publisher","first-page":"7205","DOI":"10.1038\/s41598-018-25357-0","volume":"8","author":"T Du","year":"2018","unstructured":"Du T, et al. Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism. Sci Rep. 2018;8:7205. https:\/\/doi.org\/10.1038\/s41598-018-25357-0.","journal-title":"Sci Rep"},{"key":"2141_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-015-0519-x","volume":"17","author":"AEM Reed","year":"2015","unstructured":"Reed AEM, Kutasovic JR, Lakhani SR, Simpson PT. Invasive lobular carcinoma of the breast: morphology, biomarkers and\u2019omics. Breast Cancer Res. 2015;17:1\u201311.","journal-title":"Breast Cancer Res"},{"key":"2141_CR32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13058-023-01750-0","volume":"25","author":"D Dayan","year":"2023","unstructured":"Dayan D, et al. Effect of histological breast cancer subtypes invasive lobular versus non-special type on survival in early intermediate-to-high-risk breast carcinoma: results from the SUCCESS trials. Breast Cancer Res. 2023;25:153.","journal-title":"Breast Cancer Res"},{"key":"2141_CR33","doi-asserted-by":"publisher","first-page":"5800","DOI":"10.1158\/0008-5472.CAN-21-3302","volume":"81","author":"C Fang","year":"2021","unstructured":"Fang C, Kang Y. E-cadherin: context-dependent functions of a quintessential epithelial marker in metastasis. Cancer Res. 2021;81:5800\u20132.","journal-title":"Cancer Res"},{"key":"2141_CR34","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1091\/mbc.E16-01-0058","volume":"27","author":"YI Petrova","year":"2016","unstructured":"Petrova YI, Schecterson L, Gumbiner BM. Roles for e-cadherin cell surface regulation in cancer. Mol Biol Cell. 2016;27:3233\u201344. https:\/\/doi.org\/10.1091\/mbc.E16-01-0058.","journal-title":"Mol Biol Cell"},{"key":"2141_CR35","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ejca.2003.08.015","volume":"40","author":"MC Mathieu","year":"2004","unstructured":"Mathieu MC, et al. The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. Eur J Cancer. 2004;40:342\u201351. https:\/\/doi.org\/10.1016\/j.ejca.2003.08.015.","journal-title":"Eur J Cancer"},{"key":"2141_CR36","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.3390\/cancers13153695","volume":"13","author":"M Christgen","year":"2021","unstructured":"Christgen M, et al. Lobular breast cancer: histomorphology and different concepts of a special spectrum of tumors. Cancers. 2021;13:3695.","journal-title":"Cancers"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-025-02141-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-025-02141-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-025-02141-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:44:25Z","timestamp":1762166665000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-025-02141-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2141"],"URL":"https:\/\/doi.org\/10.1186\/s13058-025-02141-3","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"28 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Seoul National University Hospital (approval number: H-2308-007-1455). The requirement for informed consent was waived by the Ethics Committee because of the retrospective nature of the study and the minimal risk to the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HBL and WH are co-founders and members of the DCGen Co., Ltd board of directors. HBL received research funding from Devicor Medical Product, Inc., and consulting fees from Need Inc., outside the current work. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"194"}}